Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svrcek

Showing results (181-190 of 299) with videos related to

Pageof 30
Sort By:
The American Journal of Gastroenterology|January 21, 2016
Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel DiseaseMagali Svrcek, Laurent Beaugerie, Julien Kirchgesner, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
High prevalence of NTRK fusions in sporadic dMMR/MSI mCRC RAS/RAF wild-type: an opportunity for a post-immune checkpoint inhibitors progression rescue strategyM Svrcek, A Cayre, T Samaille, et al.
Nanoscale|March 5, 2016
Energy band diagram of device-grade silicon nanocrystalsM Macias-Montero, S Askari, S Mitra, et al.
Clinics and Research in Hepatology and Gastroenterology|November 15, 2023
Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's diseaseMathieu Uzzan, Victoria Assouline, Edouard Chambenois, et al.
Oncoimmunology|September 14, 2016
Extracellular HSP110 skews macrophage polarization in colorectal cancerKevin Berthenet, Christophe Boudesco, Ada Collura, et al.
Bulletin Du Cancer|June 30, 2015
[DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?]Romain Cohen, Pascale Cervera, Magali Svrcek, et al.
Therapeutic Advances in Medical Oncology|November 1, 2021
Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary mucinous ovarian carcinomaAlice de Malet, Magali Svrcek, Anne Kerbaol, et al.
JAMA Oncology|November 20, 2018
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency StatusRomain Cohen, Elisabeth Hain, Olivier Buhard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinomaMarc Hilmi, Jérôme Cros, Francesco Puleo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2021
Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and ComponentsShulin Zhao, Rémy Nicolle, Jérémy Augustin, et al.
Pageof 30

Showing results (181-190 of 299) with videos related to

Sort By:
Pageof 30
The American Journal of Gastroenterology|January 21, 2016
Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel DiseaseMagali Svrcek, Laurent Beaugerie, Julien Kirchgesner, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
High prevalence of NTRK fusions in sporadic dMMR/MSI mCRC RAS/RAF wild-type: an opportunity for a post-immune checkpoint inhibitors progression rescue strategyM Svrcek, A Cayre, T Samaille, et al.
Nanoscale|March 5, 2016
Energy band diagram of device-grade silicon nanocrystalsM Macias-Montero, S Askari, S Mitra, et al.
Clinics and Research in Hepatology and Gastroenterology|November 15, 2023
Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's diseaseMathieu Uzzan, Victoria Assouline, Edouard Chambenois, et al.
Oncoimmunology|September 14, 2016
Extracellular HSP110 skews macrophage polarization in colorectal cancerKevin Berthenet, Christophe Boudesco, Ada Collura, et al.
Bulletin Du Cancer|June 30, 2015
[DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?]Romain Cohen, Pascale Cervera, Magali Svrcek, et al.
Therapeutic Advances in Medical Oncology|November 1, 2021
Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary mucinous ovarian carcinomaAlice de Malet, Magali Svrcek, Anne Kerbaol, et al.
JAMA Oncology|November 20, 2018
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency StatusRomain Cohen, Elisabeth Hain, Olivier Buhard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinomaMarc Hilmi, Jérôme Cros, Francesco Puleo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2021
Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and ComponentsShulin Zhao, Rémy Nicolle, Jérémy Augustin, et al.
Pageof 30